Grantee News

A first-of-its-kind study on molecular interactions by biomedical engineers will make it easier and more efficient for scientists to develop new medicines and other therapies for diseases such as cancer, HIV, and autoimmune diseases.

A wearable monitoring device to make treatments easier and more affordable for the millions of people with swallowing disorders is about to be released into the market.

Researchers have found that very slow spontaneous blood vessel pulsations drive the clearance of substances from the brain, indicating that targeting and improving this process may help to prevent or treat amyloid-beta accumulation.

QuantX backstops radiologists with AI-enabled software that analyzes MRIs to confirm or challenge their diagnosis.

Scientists report they have created a tiny, nanosize container that can slip inside cells and deliver protein-based medicines and gene therapies of any size -- even hefty ones attached to the gene-editing tool called CRISPR.

Researchers studying six adults who had one of their brain hemispheres removed during childhood to reduce epileptic seizures found that the remaining half of the brain formed unusually strong connections between different functional brain networks, which potentially help the body to function as if the brain were intact.

Wearable and implantable devices may allow for intensive self-care for patients with kidney failure outside of the clinic.

The researchers genetically engineered CAR T cells with molecular tags, which they were able to monitor in an animal model using position emission tomography (PET) imaging.

Electrically stimulating nerves can reduce epileptic seizures, soothe chronic pain, and treat depression. Now, biomedical engineers have made a significant advance that could dramatically reduce the cost of neuromodulation therapy, increase its reliability and make it much less invasive.

The National Institutes of Health has awarded $3.4 million to a team of researchers at the University of Virginia and Virginia Tech to develop and produce a “lymph node on a chip.” This tiny, yet sophisticated physical model of the gland will be designed to help researchers better understand the inner workings of the node itself, and, thereby, the broader immune system.

Read more at UVA Today.